Cargando…
Second Cancer Onset in Myeloproliferative Neoplasms: What, When, Why?
The risk of developing a solid cancer is a major issue arising in the disease course of a myeloproliferative neoplasm (MPN). Although the connection between the two diseases has been widely described, the backstage of this complex scenario has still to be explored. Several cellular and molecular mec...
Autores principales: | Cumbo, Cosimo, Anelli, Luisa, Zagaria, Antonella, Coccaro, Nicoletta, Tarantini, Francesco, Specchia, Giorgina, Musto, Pellegrino, Albano, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954627/ https://www.ncbi.nlm.nih.gov/pubmed/35328597 http://dx.doi.org/10.3390/ijms23063177 |
Ejemplares similares
-
The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms
por: Parciante, Elisa, et al.
Publicado: (2023) -
IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis
por: Cumbo, Cosimo, et al.
Publicado: (2021) -
Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?
por: Tarantini, Francesco, et al.
Publicado: (2021) -
Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick
por: Tarantini, Francesco, et al.
Publicado: (2021) -
The JAK2 GGCC (46/1) Haplotype in Myeloproliferative Neoplasms: Causal or Random?
por: Anelli, Luisa, et al.
Publicado: (2018)